UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study

Neurology, 2020-10, Vol.95 (14), p.e1999

2020

Link zum Volltext

Verfügbarkeit prüfen

Seronegative Neuromyelitis Optica Spectrum Disorder following Exposure to Hepatitis B Vaccination

Case reports in neurology, 2015-04, Vol.7 (1), p.78-83

2015

Link zum Volltext

Verfügbarkeit prüfen

Rhabdomyolysis and Autoimmune Variant Stiff-Person Syndrome

Clinics and practice, 2016-11, Vol.6 (4), p.885

2016

Link zum Volltext

Verfügbarkeit prüfen

To diagnose or not to diagnose? Timing is the question: balancing early diagnosis of multiple sclerosis with misdiagnosis

Expert review of neurotherapeutics, 2018-05, Vol.18 (5), p.355-357

2018

Link zum Volltext

Verfügbarkeit prüfen

Unusual Late Onset of Parenchymal Neuro-Behçet Disease

Case reports in neurological medicine, 2016-01, Vol.2016, p.5720319-3

2016

Link zum Volltext

Verfügbarkeit prüfen

Ceasing Antiquated Conceptions: A Telling of the Early and Evolving History of Epilepsy

European neurology, 2020-08, Vol.83 (3), p.341-344

2020

Link zum Volltext

Verfügbarkeit prüfen

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis

The New England journal of medicine, 2022-08, Vol.387 (8), p.704-714

2022

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study

Clinical therapeutics, 2018-12, Vol.40 (12), p.2077-2087

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice

Neurology, 2019-04, Vol.92 (15), p.e1724

2019

Link zum Volltext

Verfügbarkeit prüfen

Fish soup for the falling sickness: Tracing epilepsy through Hmong and Western beliefs

Epilepsy & behavior, 2021-02, Vol.115, p.107725-107725, Article 107725

2021

Link zum Volltext

Verfügbarkeit prüfen

Results from a multicenter, randomized, double‐blind, placebo‐controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids

CNS neuroscience & therapeutics, 2022-03, Vol.28 (3), p.364-371

2022

Link zum Volltext

Verfügbarkeit prüfen

Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity

Multiple sclerosis, 2021-05, Vol.27 (6), p.883-894

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension

Multiple sclerosis, 2023-10, Vol.29 (11-12), p.1452-1464

2023

Link zum Volltext

Verfügbarkeit prüfen

Use of Calcitonin Gene-Related Peptide Monoclonal Antibodies for the Treatment of Migraines in Individuals With Multiple Sclerosis

International journal of MS care, 2023-10

2023

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study” [Clinical Therapeutics 40 (12) (2018) 2077–2087]

Clinical therapeutics, 2019-12, Vol.41 (12), p.2662-2662

2019

Link zum Volltext

Verfügbarkeit prüfen

Assessing Barriers to Adherence with the Use of Dimethyl Fumarate in Multiple Sclerosis

Clinical drug investigation, 2020, Vol.40 (1), p.73-81

2020

Link zum Volltext

Verfügbarkeit prüfen

Multiple Sclerosis and MyChart Messaging: A Retrospective Chart Review Evaluating Its Use

International journal of MS care, 2022-11, Vol.24 (6), p.271-274

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of CD40L with Frexalimab in Multiple Sclerosis

The New England journal of medicine, 2024-02, Vol.390 (7), p.589-600

2024

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Early Multiple Sclerosis: Subgroup Analysis of RESPOND

Neurology and therapy, 2021-06, Vol.10 (1), p.169-182

2021

Link zum Volltext

Verfügbarkeit prüfen

Tolerability and efficacy of colestipol hydrochloride for accelerated elimination of teriflunomide

Expert review of clinical pharmacology, 2017-12, Vol.10 (12), p.1403-1407

2017

Link zum Volltext

Verfügbarkeit prüfen

2265 Long-term efficacy of ofatumumab in patients with relapsing multiple sclerosis

BMJ neurology open, 2022-08, Vol.4 (Suppl 1), p.A26-A26

2022

Link zum Volltext

Verfügbarkeit prüfen

Medical marijuana in neurology

Expert review of neurotherapeutics, 2014-12, Vol.14 (12), p.1453-1465

2014

Link zum Volltext

Verfügbarkeit prüfen

CLICK-MS and MASTER-2 Phase IV trial design: cladribine tablets in suboptimally controlled relapsing multiple sclerosis

Neurodegenerative disease management, 2021-04, Vol.11 (2), p.99

2021

Link zum Volltext

Verfügbarkeit prüfen

Patient perceived changes in sexual dysfunction after initiation of natalizumab for multiple sclerosis

Multiple sclerosis journal - experimental, translational and clinical, 2018-04, Vol.4 (2), p.2055217318781989-2055217318781989

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Englisch
(51)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(30)
Humans
(18)
Multiple Sclerosis
(15)
Neurosciences & Neurology
(15)
Clinical Neurology
(14)
Neurosciences
(8)
Female
(7)
Male
(6)
Pharmacology & Pharmacy
(6)
Animals
(5)
Monoclonal Antibodies
(5)
Neurology
(5)
Adult
(4)
Clinical Medicine
(4)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(4)
Patient-Reported Outcomes
(4)
Patients
(4)
Quality Of Life
(4)
Biological And Medical Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

Seronegative Neuromyelitis Optica Spectrum Disorder following Exposure to Hepatitis B Vaccination

Rhabdomyolysis and Autoimmune Variant Stiff-Person Syndrome

To diagnose or not to diagnose? Timing is the question: balancing early diagnosis of multiple sclerosis with misdiagnosis

Unusual Late Onset of Parenchymal Neuro-Behçet Disease

Ceasing Antiquated Conceptions: A Telling of the Early and Evolving History of Epilepsy

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis

Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice

Fish soup for the falling sickness: Tracing epilepsy through Hmong and Western beliefs

Results from a multicenter, randomized, double‐blind, placebo‐controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids

Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity

Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension

Use of Calcitonin Gene-Related Peptide Monoclonal Antibodies for the Treatment of Migraines in Individuals With Multiple Sclerosis

Corrigendum to “Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study” [Clinical Therapeutics 40 (12) (2018) 2077–2087]

Assessing Barriers to Adherence with the Use of Dimethyl Fumarate in Multiple Sclerosis

Multiple Sclerosis and MyChart Messaging: A Retrospective Chart Review Evaluating Its Use

Inhibition of CD40L with Frexalimab in Multiple Sclerosis

Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Early Multiple Sclerosis: Subgroup Analysis of RESPOND

Tolerability and efficacy of colestipol hydrochloride for accelerated elimination of teriflunomide

2265 Long-term efficacy of ofatumumab in patients with relapsing multiple sclerosis

Medical marijuana in neurology

CLICK-MS and MASTER-2 Phase IV trial design: cladribine tablets in suboptimally controlled relapsing multiple sclerosis

Patient perceived changes in sexual dysfunction after initiation of natalizumab for multiple sclerosis

Suchergebnisse filtern